Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Frontiers in EndocrinologyOpen Access

A key role of the PGC-1α/ERR-α pathway in regulation of angiogenic factors in proliferative diabetic retinopathy

View Full Paper
Ask AI
Bookmark
Share

Authors

AEAhmed M. Abu El‐AsrarMNMohd Imtiaz NawazAAAjmal Ahmad

Discussion

Loading...

Member takes

Overview

Analysis reveals PGC-1α and ERR-α increase angiogenic factors in proliferative diabetic retinopathy, suggesting therapeutic targets.

Key Points

  • Increased expression of PGC-1α and ERR-α correlates with angiogenic activity in proliferative diabetic retinopathy.
  • Western blot and ELISA analyses confirmed that VEGF and angiopoietin 2 levels were elevated in PDR vitreous fluid samples.
  • Rat model studies demonstrated that diabetes induces upregulation of PGC-1α and ERR-α in retinal tissues, linked to angiogenesis.
  • Inhibiting PGC-1α and ERR-α in Müller cells significantly reduced the upregulation of angiogenic markers under diabetic conditions.

Cite This Study

El‐Asrar et al. (2025) studied this question.

synapsesocial.com/papers/68c23fc3b210217d6479799fhttps://doi.org/10.3389/fendo.2025.1615103
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Vitreous Olink Proteomics Uncovers Novel Inflammatory Proteins in Patients with Proliferative Diabetic Retinopathy2025
  2. 2Combined proteomics and metabolomics analyses revealed molecular signatures associated with proliferative diabetic retinopathy2025
  3. 3Proliferative diabetic retinopathy subtypes defined by immune defense and endothelial mitochondrial dysfunction2025
  4. 4Epac1 deletion attenuates Müller glial pathological activation and mitigates retinal neurodegeneration in ischemia-induced retinopathy2025
  5. 5Ginsenoside Rg1 alleviates HG-induced autophagy of retinal microvascular endothelial cells by activating ACE2/Ang1-7/Mas in vitro2025